SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9401)6/9/1998 6:39:00 AM
From: Sal Milani  Read Replies (1) | Respond to of 23519
 
To All - If Viagra has 280,000 scripts/week and 30% or 84,000 are failures, where will these patients turn. Won't a large fraction try MUSE ? My guess is that at least half or 42,000/week will try MUSE. That looks good to me.
Sal



To: VLAD who wrote (9401)6/9/1998 8:49:00 AM
From: Diamondcutter  Read Replies (1) | Respond to of 23519
 
To all: What is the level of U.S. scripts VVUS needs to breakeven on earnings. I realize the growing international sales adds complexity, but can anyone give me a ballpark number. What does it take for the 1999 earnings numbers? Thanks in advance.

Diamondcutter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News